JPMorgan Chase & Co’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
6,757
-1,405
| -17% | -$81.1K | ﹤0.01% | 4169 |
|
|
2025
Q1 | $540K | Sell |
8,162
-6,474
| -44% | -$429K | ﹤0.01% | 3961 |
|
|
2024
Q4 | $924K | Buy |
14,636
+8,280
| +130% | +$522K | ﹤0.01% | 3849 |
|
|
2024
Q3 | $298K | Buy |
6,356
+6,268
| +7,123% | +$294K | ﹤0.01% | 4287 |
|
|
2024
Q2 | $4.02K | Sell |
88
-570
| -87% | -$26K | ﹤0.01% | 5407 |
|
|
2024
Q1 | $25.2K | Sell |
658
-13,609
| -95% | -$522K | ﹤0.01% | 5177 |
|
|
2023
Q4 | $653K | Buy |
+14,267
| New | +$653K | ﹤0.01% | 3767 |
|
|
2022
Q4 | – | Sell |
-7,400
| Closed | -$250K | – | 5579 |
|
|
2022
Q3 | $250K | Buy |
+7,400
| New | +$250K | ﹤0.01% | 4070 |
|